Ellagitannin (BJA3121), an anti-proliferative natural polyphenol compound, can regulate the expression of MiRNAs in HepG2 cancer cells

Phytotherapy Research

Volumn 23, Issue 6, 2009, Pages 778-784

  Wen, Xiao Yun ^a   Wu, Shao Yu ^a   Li, Zhi Qin ^a   Liu, Zhong Qiu ^a   Zhang, Jia Jie ^a   Wang, Guang Fa ^a   Jiang, Zhi Hong ^b   Wu, Shu Guang ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Antiproliferation; Ellagitannin; miRNAs; Target genes

Indexed keywords

BJA 3121; ELLAGITANNIN; MICRORNA; UNCLASSIFIED DRUG; FLAVONOID; PHENOL DERIVATIVE; POLYPHENOLS; TANNIN;

ARTICLE; CANCER CELL; CELL PROLIFERATION; CELL STRAIN HEPG2; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; BALANOPHORACEAE; CHEMICAL STRUCTURE; CHEMISTRY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; METABOLISM; TUMOR CELL LINE;

BALANOPHORA; JAPONICA;

BALANOPHORACEAE; CELL LINE, TUMOR; CELL PROLIFERATION; FLAVONOIDS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROLYZABLE TANNINS; MICRORNAS; MOLECULAR STRUCTURE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOLS;

EID: 67149144844     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2616     Document Type: Article

References (30)

1. Ambros V. 2004. The functions of animal microRNAs. Nature 431: 350-355. (Pubitemid 39265675)
2. Blower PE, Verducci JS, Lin S, Zhou J, Chung JH, Dai Z, Liu CG, Reinhold W, Lorenzi PL, Kaldjian EP, Croce CM, Weinstein JN, Sadee W. 2007. MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol Cancer Ther 6: 1483-1491. (Pubitemid 46954015)
3. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Alder H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM. 2002. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99: 15524-15529. (Pubitemid 35403967)
4. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizn M, Rattan S, Bullrich F, Negrini M, Croce CM. 2004. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004. (Pubitemid 38327724)
5. Cao W, Ma SL, Tang J, Shi J, Lu Y. 2006. A combined treatment TNF-alpha/doxorubicin alleviates the resistance of MCF-7/Adr cells to cytotoxic treatment . Biochim Biophys Acta 1763: 182-187.
6. Croce CM, Calin GA. 2005. MiRNAs, cancer, and stem cell division. Cell 122: 6-7. (Pubitemid 40977933)
7. Cummins JM, He Y, Leary RJ, Pagliarini R, Jr Diaz LA, Sjoblom T, Barad O, Bemwich Z, Szafranska AE, Labourier E, Raymond CK, Roberts BS, Juhl H, Kinzler KW, Vogelstein B, Velculescu VE. 2006. The colorectal microRNAome. Proc Natl Acad Sci USA 103: 3687-3692. (Pubitemid 43376616)
8. Garzon R, Pichiorri F, Palumbo T, Visentini M, Aqeilan R, Cimmino A, Wang H, Sun H, Volinia S, Alder H, Calin GA, Liu CG, Andreeff M, Croce CM. 2007. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 26: 4148-4157. (Pubitemid 46920170)
9. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. 2006. MiRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-D144.
10. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. 2007. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105. (Pubitemid 46991392)
11. Gusev Y, Schmittgen TD, Lerner M, Postier R, Brackett D. 2007. Computational analysis of biological functions and pathways collectively targeted by co-expressed microRNAs in cancer. BMC Bioinformatics 8(Suppl 7): S16. (Pubitemid 352015088)
12. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM. 2005. A microRNA polycistron as a potential human oncogene. Nature 435: 828-833. (Pubitemid 40839734)
13. He L, He X, Lowe SW, Hannon GJ. 2007. MicroRNAs join the p53 network- another piece in the tumour-suppression puzzle. Nat Rev Cancer 7: 819-822. (Pubitemid 350006254)
14. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Guerzoli P, Negrini M, Croce CM. 2005. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070. (Pubitemid 41161233)
15. Jiang ZH, Hirose Y, Iwata H, Sakamoto S, Tanaka T, Kouno I. 2001. Caffeoyl, coumaroyl, galloyl, and hexahydroxydiphenoyl glucoses from Balanophora japonica. Chem Pharm Bull (Tokyo) 49: 887-892. (Pubitemid 32624860)
16. Kasashima K, Nakamura Y, Kozu T. 2004. Altered expression profiles of microRNAs during TPA-induced differentiation of HL-60 cells. Biochem Biophys Res Commun 322: 403-410. (Pubitemid 39490318)
17. Kuhn DE, Martin MM, Feldman DS, Jr Terry AV, Nuovo GJ, Elton TS. 2008. Experimental validation of miRNA targets. Methods 44: 47-54. (Pubitemid 350297983)
18. Lewis BP, Burge CB, Bartel DP. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. (Pubitemid 40094598)
19. Meng F, Henson R, Lang M, Wehbe H, Mabeshwari S, Mendell JT, Jiang J, Schmittgen TD, Patel T. 2006. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130: 2113-2129. (Pubitemid 43816961)
20. Meng F, Wehbe-Janek H, Henson R, Smith H, Patel T. 2008. Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene 27: 378-386.
21. Pogribny IP, Tryndyak VP, Boyko A, Rodriguez-Juarez R, Beland FA, Kovalchuk O. 2007. Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposure. Mutat Res 619: 30-37. (Pubitemid 46602445)
22. Rosa A, Ballarino M, Sorrentino A, Sthandier O, De Angelis FG, Marchioni M, Masella B, Guarini A, Fatica A, Peschle C, Bozzoni I. 2007. The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proc Natl Acad Sci USA 104: 19849-19854.
23. Rossi L, Bonmassar E, Faraoni I. 2007. Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro. Pharmacol Res 56: 248-253. (Pubitemid 47321208)
24. Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, Schwartz G, Wells W, Kauppinen S, Cole CN. 2007. Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 67: 11612-11620.
25. Sethupathy P, Corda B, Hatzigeorgiou AG. 2006. TarBase: A comprehensive database of experimentally supported animal microRNA targets. RNA 12: 192-197. (Pubitemid 43121923)
26. Shah YM, Morimura K, Yang Q, Tanabe T, Takagi M, Gonzalez FJ. 2007. Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation. Mol Cell Biol 27: 4238-4247. (Pubitemid 46906549)
27. Taganov KD, Boldin MP, Baltimore D. 2007. MicroRNAs and immunity: tiny players in a big field. Immunity 26: 133-137. (Pubitemid 46329443)
28. Thompson BJ, Cohen SM. 2006. The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila . Cell 126: 767-774. (Pubitemid 44233623)
29. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261. (Pubitemid 43271657)
30. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchelli A, Ward MR, Yao G, Medina A, O'brien-Jenkins A, Katsaros D, Hatzigeorgiou A, Gimotty PA, Weber BL, Coukos G. 2006. MicroRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 103: 9136-9141.